title: Effects of gonadotropin-releasing hormone on bioactivity of follicle-stimulating hormone (FSH) and microstructure of FSH, luteinizing hormone and sex hormone-binding globulin in a testosterone-based contraceptive trial: evaluation of responders and non-responders.
abstract: Only a proportion of normal men participating in testosterone-based contraceptive trials develop azoospermia (responders). This study analyzed whether serum follicle-stimulating hormone (FSH), luteinizing hormone (LH) and sex hormone-binding globulin (SHBG) are qualitatively different between responders and non-responders. Determination of in vitro bioactive FSH after stimulation with gonadotropin-releasing hormone (GnRH) and analysis of molecular heterogeneity of serum FSH, LH and SHBG was carried out by chromatofocusing and concanavalin-A affinity chromatography in eight men who had participated in a previous contraceptive study with testosterone buciclate. Blood was withdrawn at 15-min intervals on two basal occasions and 30, 45 and 60 min after i.v. administration of GnRH (100 micrograms). Pools of sera were separated by chromatofocusing in the pH range 3-6 and by lectin chromatography on concanavalin A. Immunoreactive FSH, LH and SHBG were assayed in the eluates. Bioactive FSH was analyzed by the rat Sertoli cell bioassay. Serum bioactive FSH increased after GnRH stimulation, without significant differences between responders and non-responders. The chromatofocusing profiles of serum FSH showed a significant shift towards the less acidic region after GnRH. The isoform distribution was similar in responders and non-responders. No significant differences were found in the relative proportion of FSH, LH and SHBG retained by concanavalin A. It is concluded that the extent of suppression of sperm production by androgen administration cannot be foreseen either on the basis of the response of bioactive FSH to GnRH administration or from the glycosylation pattern of serum FSH, LH and SHBG.
authors.affiliation: Institute of Reproductive Medicine of the University, WHO Collaborating Center for Research in Human Reproduction, Münster, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Simoni
authors.forename: J
authors.initials: J
authors.lastname: Peters
authors.forename: H M
authors.initials: HM
authors.lastname: Behre
authors.forename: S
authors.initials: S
authors.lastname: Kliesch
authors.forename: E
authors.initials: E
authors.lastname: Leifke
authors.forename: E
authors.initials: E
authors.lastname: Nieschlag
mesh_terms: D000328:Adult; D000818:Animals; D002846:Chromatography, Affinity; D003208:Concanavalin A; D003272:Contraceptive Agents, Male / Q000494:pharmacology*; D005640:Follicle Stimulating Hormone / Q000097:blood* / Q000737:chemistry*; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology*; D006801:Humans; D007536:Isomerism; D007986:Luteinizing Hormone / Q000737:chemistry*; D008297:Male; D051381:Rats; D012738:Sex Hormone-Binding Globulin / Q000737:chemistry*; D013739:Testosterone / Q000494:pharmacology*
chemical_list: D003272:Contraceptive Agents, Male; D012738:Sex Hormone-Binding Globulin; D003208:Concanavalin A; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone